![]() ![]() In these preliminary studies, the vaccine has been demonstrated to be safe and have a reasonable expectation of efficacy. The initial development work and studies for the vaccine, which Zoetis shared last fall at the 6 th World One Health Congress virtual event, were completed on dogs and cats. “It’s a great demonstration of how our CTED team can apply our capabilities to emerging infectious diseases, adapt quickly to shifting market needs, and play an important role in promoting public health by advancing animal care.” Mahesh Kumar, senior vice president of global biologics at Zoetis. “We are proud to be able to assist the San Diego Zoo Global veterinary staff and the animals in their care with their recent COVID-19 concerns,” said Dr. Recently, our R&D team responded to a request from the San Diego Zoo after COVID-19 infected the zoo’s Great Apes and has provided a supply of experimental SARS-CoV-2 vaccines for the zoo’s emergency use in its Great Ape population. Led by researchers and scientists in our Center for Transboundary and Emerging Diseases (CTED), Zoetis initiated development activities for a new vaccine last year based on initial concerns about SARS-CoV-2 in domestic animals. Initial work on a vaccine that could be used in cats and dogs leads to emergency use in other species ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |